Stereotactic body radiotherapy for adrenal oligometastasis in lung cancer patients.

CONCLUSION: SBRT was effective and safe in lung cancer adrenal metastases. A dose-response relationship was found between BED10 >72 Gy and better local control. No significant toxicity was registered thanks to the respect of dose constraints and suspension of chemo- and target-therapies. ADVANCES IN KNOWLEDGE: SBRT with a BED10 >72 Gy is an effective treatment for adrenal oligometastatic lung cancer patients. PMID: 32822540 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32822540?dopt=Abstract

Source: The British Journal of Radiology - August 20, 2020 Category: Radiology Authors: Arcidiacono F, Aristei C, Marchionni A, Italiani M, Fulcheri CPL, Saldi S, Casale M, Ingrosso G, Anselmo P, Maranzano E Tags: Br J Radiol Source Type: research